Over the past year, analysts have steadily increased their consensus price target for Reinsurance Group of America (RGA), reflecting growing confidence in the company’s outlook. One year ago the average target stood at $219.63; three months ago it rose to $228.25, and as of last month it climbed further to $237.50. Notably, Wells Fargo has set its own target at $238, signaling potential upside. This represents a total increase of $17.87 over twelve months, underscoring positive sentiment around RGA’s growth prospects in traditional life and health reinsurance markets worldwide.

For the quarter ending December 2025, Wall Street analysts expect RGA to report earnings per share of $5.86 and revenue of approximately $6.25 billion. Over the past 30 days the consensus EPS estimate has been revised upward by 0.6%, indicating improved analyst confidence in the company’s near-term performance. These upward revisions are critical, as they often drive investor reaction ahead of the official earnings release and can lead to meaningful stock price movements depending on whether actual results exceed or fall short of estimates.

RGA’s current valuation metrics provide insight into how the market is pricing its shares relative to fundamentals. The company trades at a price-to-earnings ratio of approximately 15.44 and a price-to-sales ratio near 0.60. On an enterprise value basis, RGA’s EV-to-sales multiple is around 0.65 and its EV-to-operating cash flow ratio stands at roughly 2.98. The stock’s earnings yield is about 6.48%, while its debt-to-equity ratio of 0.44 indicates a moderate leverage profile. Together, these figures suggest that investors are valuing RGA conservatively relative to peers, even as expectations for earnings growth rise.

RGA is scheduled to release fourth-quarter results on February 5, 2026, with a conference call following on February 6. Investors will be closely watching whether the company can meet or beat the current EPS and revenue estimates, as well as management’s commentary on reserve development and capital deployment. Key areas of focus include underwriting margins in the life reinsurance segment, updates on new business strain in financial solutions, and any changes to the company’s capital return program. These factors will be pivotal in determining RGA’s stock trajectory in the weeks following the report.